Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 85 peer-reviewed journal articles Updated
Clinical Immunology · Combined Immunodeficiency with Granulomas and/or Autoimmunity

Combined immunodeficiency with granulomas (and/or autoimmunity): A Patient Guide

At a Glance

Combined immunodeficiency with granulomas or autoimmunity is a rare inherited immune disorder that causes recurrent or unusual infections and misdirected inflammation. Care often includes antibody and antimicrobial protection, avoiding live vaccines, and considering stem cell transplant.

Combined immunodeficiency with granulomas (and/or autoimmunity) is a rare genetic spectrum where the immune system is fundamentally misconfigured. Most people are born with an immune system that can produce millions of unique “keys” to unlock and destroy different germs. In this condition, the genetic machinery responsible for creating these keys—most commonly the RAG1, RAG2, or Artemis (DCLRE1C) genes—only works partially [1][2]. This state of “partial function” is known as a hypomorphic mutation. Because the machinery is leaky rather than completely broken, the body can produce some immune cells, but they lack the diversity and “training” needed for a healthy life [3][4].

This lack of diversity creates a “double-edged sword” within the body. On one side, the immune system is too weak to recognize and fight off specific invaders, leading to recurrent or unusual infections [5]. On the other side, the few immune cells that do develop are often dysregulated. They may fail to distinguish between harmful germs and the body’s own tissues, leading to autoimmunity (where the body attacks itself) or the formation of granulomas—small, chronic areas of inflammation that the body sometimes uses to wall off perceived threats it cannot fully eliminate [6][7]. These granulomas frequently appear on the skin or in internal organs. While they can have sterile inflammatory causes, they are also sometimes triggered by “hidden” traces of viruses, such as the weakened rubella virus found in common childhood vaccines, or by mycobacteria and fungi [8][9].

Because the immune system is so fragile, certain standard medical practices require immediate adjustment. Most notably, live-attenuated vaccines (such as MMR, rotavirus, or the chickenpox vaccine) should be strictly withheld while this condition is being evaluated or treated, as the weakened germs in these vaccines can grow unchecked, leading to serious illness or chronic inflammatory complications like the granulomas mentioned above [10][11][12][8]. Management typically focuses on a “bridge” of protective measures, which may include antibody infusions and targeted antimicrobial medications chosen by your immunology team to prevent infections while a long-term plan is developed [13].

The ultimate treatment with curative potential for the underlying immune defect is a Hematopoietic Stem Cell Transplant (HSCT) [14]. By replacing the original immune system with healthy donor stem cells, the body can potentially develop a full and diverse library of T and B cells [9]. While the transplant process is complex and carries major risks—including graft failure, severe infections, organ toxicity, and graft-versus-host disease (GVHD)—early intervention can stop the progression of the disease for many patients [15][14]. Navigating this diagnosis means moving from a place of medical mystery to a structured path of specialized care, focused on protecting the body today while preparing for a potential immune system transplant tomorrow.

In this guide

6 chapters

01

Understanding Combined Immunodeficiency with Granulomas

Learn what combined immunodeficiency with granulomas means, including genetic causes, infections, autoimmunity, testing, and treatment options such as HSCT.

02

Symptoms, Granulomas, and Warning Signs

Learn the symptoms of combined immunodeficiency with granulomatosis, including infections, granulomas, autoimmune signs, and when to seek urgent care.

03

The Biology and Genetics of Combined Immunodeficiency

Learn how combined immunodeficiency with granulomas affects immune-cell development, V(D)J recombination, RAG and Artemis genes, and diagnostic testing.

04

Understanding Your Granuloma Biopsies

Learn how granuloma biopsies are evaluated in combined immunodeficiency with granulomas, including cultures, stains, PCR, and sequencing for hidden infection.

05

Day-to-Day Management and Infection Prevention

Learn infection prevention for combined immunodeficiency with granulomas, including vaccine safety, immunoglobulin, prophylaxis, and pre-transplant care.

06

The Path to Cure: Stem Cell Transplant and Long-Term Outlook

Learn how stem cell transplant may treat combined immunodeficiency with granulomatosis, including timing, conditioning, risks, recovery, and long-term follow-up.

Common questions in this guide

What causes this form of combined immunodeficiency?
It is usually linked to inherited changes in RAG1, RAG2, or DCLRE1C, the gene that makes the Artemis protein. These changes may leave the genes partly working, so some immune cells develop but do not have enough variety or normal control.
What does a hypomorphic mutation mean for immune function?
A hypomorphic mutation is a genetic change that reduces, but does not completely eliminate, a gene’s activity. The immune system may therefore make some T and B cells while still failing to recognize germs reliably or control inflammation.
Why can live vaccines be dangerous with this condition?
Live-attenuated vaccines contain weakened germs that can multiply or persist when immune defenses are fragile. MMR, rotavirus, and chickenpox vaccines should be withheld while the condition is being evaluated or treated, according to the immunology team’s guidance.
How are granulomas and their possible triggers evaluated?
Granulomas may come from sterile inflammation or from hidden infections, including mycobacteria, fungi, or vaccine-related rubella virus. The immunology team may investigate these possibilities and choose targeted antimicrobial treatment when an infection is suspected.
What treatment can protect someone while a transplant plan is being made?
Antibody infusions can supply infection-fighting antibodies, and targeted antimicrobial medicines may help prevent or treat infections. These measures can serve as a temporary bridge while the immunology and transplant teams develop a long-term plan.
Can a stem cell transplant correct the underlying immune defect?
Hematopoietic stem cell transplant, or HSCT, can potentially replace the faulty immune system with healthy donor stem cells and rebuild a more diverse immune response. It is complex and can cause graft failure, severe infections, organ toxicity, or graft-versus-host disease, so timing and eligibility require a specialist team.
What should household members know about vaccines?
The patient should avoid live-attenuated vaccines while the condition is being evaluated or treated. Ask the immunology team which vaccines are appropriate for household members and whether any precautions are needed around the patient.

Get notified when new evidence is published on Combined immunodeficiency with granulomatosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    An Update on Inborn Errors of V(D)J Recombination.

    Schim van der Loeff I, Ahuja M, Chen R, et al.

    Physiology (Bethesda, Md.) 2026; (41(6)):0 doi:10.1152/physiol.00004.2026.

    PMID: 41902554
  2. 2

    Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.

    Felgentreff K, Lee YN, Frugoni F, et al.

    The Journal of allergy and clinical immunology 2015; (136(1)):140-150.e7.

    PMID: 25917813
  3. 3

    Characterization of T and B cell repertoire diversity in patients with RAG deficiency.

    Lee YN, Frugoni F, Dobbs K, et al.

    Science immunology 2016; (1(6)) doi:10.1126/sciimmunol.aah6109.

    PMID: 28783691
  4. 4

    Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.

    Meshaal SS, El Hawary RE, Abd Elaziz DS, et al.

    Clinical and experimental immunology 2019; (195(2)):202-212 doi:10.1111/cei.13222.

    PMID: 30307608
  5. 5

    Factors associated with and kinetics of anti-IFN-α autoantibodies in RAG1/2 deficiency.

    Wang C, Potts DE, Sun B, et al.

    The journal of allergy and clinical immunology. Global 2025; (4(3)):100521 doi:10.1016/j.jacig.2025.100521.

    PMID: 40697949
  6. 6

    Omenn Syndrome and DNA recombination defects.

    Yachie A

    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2017; (40(3)):179-189 doi:10.2177/jsci.40.179.

    PMID: 28747605
  7. 7

    Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

    Walter JE, Rosen LB, Csomos K, et al.

    The Journal of clinical investigation 2015; (125(11)):4135-48.

    PMID: 26457731
  8. 8

    Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders.

    Buchbinder D, Hauck F, Albert MH, et al.

    Journal of clinical immunology 2019; (39(1)):81-89 doi:10.1007/s10875-018-0581-0.

    PMID: 30607663
  9. 9

    Case Report: Rubella Virus-Induced Cutaneous Granulomas in Two Pediatric Patients With DNA Double Strand Breakage Repair Disorders - Outcome After Hematopoietic Stem Cell Transplantation.

    Baumann U, Schulte JH, Groß JP, et al.

    Frontiers in immunology 2022; (13()):886540 doi:10.3389/fimmu.2022.886540.

    PMID: 35720367
  10. 10

    Newborn screening for severe combined immunodeficiency-Coming to a region near you soon.

    Elliman DAC, Gennery AR

    Clinical and experimental immunology 2021; (205(3)):343-345 doi:10.1111/cei.13642.

    PMID: 34235744
  11. 11

    Persistent infection with a rotavirus vaccine strain in a child suffering from Severe Combined Immunodeficiency in Argentina.

    Palau MJ, Vescina CM, Regairaz L, et al.

    Revista Argentina de microbiologia 2021; (53(3)):216-219 doi:10.1016/j.ram.2020.10.002.

    PMID: 33526290
  12. 12

    Case Report: Infant with vaccine-associated paralytic poliomyelitis unveils global disparities in care for inborn errors of immunity.

    Chan CM, Fong ESS, Yeo DYC, et al.

    Frontiers in immunology 2026; (17()):1751423 doi:10.3389/fimmu.2026.1751423.

    PMID: 41727494
  13. 13

    Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.

    Dorsey MJ, Wright NAM, Chaimowitz NS, et al.

    Journal of clinical immunology 2021; (41(1)):38-50 doi:10.1007/s10875-020-00865-9.

    PMID: 33006109
  14. 14

    Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

    Schuetz C, Gerke J, Ege M, et al.

    Blood 2023; (141(7)):713-724 doi:10.1182/blood.2022017667.

    PMID: 36279417
  15. 15

    Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.

    Punwani D, Kawahara M, Yu J, et al.

    Human gene therapy 2017; (28(1)):112-124 doi:10.1089/hum.2016.064.

    PMID: 27611239

This page is for informational purposes only and does not constitute medical advice. Decisions about live vaccines, infection prevention, and stem cell transplantation should be made with your immunologist and transplant team.